Study of ART0380 in Patients With Biologically Selected Solid Tumors

NCT05798611 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

36

Enrollment

INDUSTRY

Sponsor class

Stopped Sponsor decision, not for reasons affecting the benefit-risk balance.

Conditions

Advanced Solid Tumor
Recurrent Endometrial Cancer
Metastatic Cancer

Interventions

DRUG: ART0380

Sponsor

Artios Pharma Ltd